Company Steminent Biotherapeutics, Inc

Equities

7729

TW0007729006

Biotechnology & Medical Research

End-of-day quote Taipei Exchange 18:00:00 2024-05-30 EDT 5-day change 1st Jan Change
30.95 TWD +3.17% Intraday chart for Steminent Biotherapeutics, Inc +6.17% -.--%

Business Summary

Steminent Biotherapeutics Inc is a Taiwan-based trading company mainly engaged in the research and development of new stem cell drugs and the development of allogeneic mesenchymal stem cell technology platforms. The Company's main product is the new stem cell drug product Stemchymal. The new stem cell drug product Stemchymal is used to treat spinocerebellar ataxia, Huntington's disease, acute ischemic stroke, acute inflammatory indications and other diseases.

Managers

Managers TitleAgeSince
Chief Executive Officer - 18-11-25

Members of the board

Members of the board TitleAgeSince
Director/Board Member 52 21-12-07
Director/Board Member - 20-09-14
Chief Executive Officer - 18-11-25

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 55,795,094 47,420,250 ( 84.99 %) 0 84.99 %

Company contact information

Steminent Biotherapeutics, Inc.

16 Wenhu Street Neihu District

114006, Taipei

+

http://www.steminent.com
address Steminent Biotherapeutics, Inc(7729)
  1. Stock Market
  2. Equities
  3. 7729 Stock
  4. Company Steminent Biotherapeutics, Inc